• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US UNK HIP ACETABULAR CUP PINNACLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US UNK HIP ACETABULAR CUP PINNACLE Back to Search Results
Catalog Number UNK HIP ACETABULAR CUP
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Hemorrhage/Bleeding (1888); Myocardial Infarction (1969)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Article entitled "a randomized, double-blind, placebo controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty" written by a.Clavé, r.Gérard, j.Lacroix, c.Baynat, m.Danguy des déserts, f.Gatineau, and d.Mottier published by the bone & joint journal in 2019 was reviewed.The study aimed to determine whether two intravenous (iv) txa regimens (a three-hour two-dose (shorttxa) and 11-hour four-dose (long-txa) were more effective than placebo in reducing perioperative real blood loss (rbl, between baseline and day 3 postoperatively) in patients undergoing tha who receive rivaroxaban as thromboprophylaxis.The secondary aim was to assess the non-inferiority of the reduction of blood loss of the short protocol versus the long protocol.229 patient were implanted with a corail stem and pinnacle cup.The patient were divided into three groups- placebo (75 patients), short-txa (76 patients), and long-txa (78 patients).Adverse event involving depuy ¿ synthes products: placebo group ¿ minor bleeding (2 patients), major bleeding (9 patients), blood transfusions >2rbc units (6 patients) short-txa ¿ minor bleeding (1 patient), major bleeding (1 patient), blood transfusions >2rbc units (2 patients) long-txa ¿ minor bleeding (0 patients), major bleeding (4 patients), blood transfusions >2rbc units (3 patients), acute coronary syndrome (1 patient), bleeding leading to re-operation (2 patients).
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.This complaint was opened to document complaints derived through a journal article review.Follow-ups were done to try and obtain additional information from the author of the journal article.No further information was received.Device history lot: a manufacturing record evaluation (mre), was not possible because the required lot code was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HIP ACETABULAR CUP PINNACLE
Type of Device
HIP ACETABULAR CUP
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key12665713
MDR Text Key277438441
Report Number1818910-2021-23051
Device Sequence Number1
Product Code JDI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK HIP ACETABULAR CUP
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/08/2021
Initial Date FDA Received10/20/2021
Supplement Dates Manufacturer Received10/26/2021
Supplement Dates FDA Received10/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-